{
 "meta": {
  "source": "U.S. SEC EDGAR",
  "latest_filing_day": "2026-10-23",
  "updated_at": "2026-10-26T06:30:26.585Z",
  "licence": "CC BY 4.0 — credit equitycapital.markets and the SEC",
  "docs": "https://equitycapital.markets/api"
 },
 "data": {
  "company": {
   "cik": 1806540,
   "name": "Lycia Therapeutics, Inc.",
   "sic": "2836",
   "sic_description": "Biological Products, (No Diagnostic Substances)",
   "state_of_incorporation": "DE",
   "business_address": "CA",
   "tickers": [
    "LYCA"
   ],
   "exchanges": [
    "Nasdaq"
   ],
   "first_periodic_report_date": null,
   "is_spac": false,
   "page": "https://equitycapital.markets/company/1806540"
  },
  "offerings": [
   {
    "offering_id": "1806540-0001628280-26-064973",
    "cik": 1806540,
    "file_number": "333-299300",
    "label": "IPO",
    "status": "Final prospectus",
    "first_filed": "2026-10-05",
    "last_event_date": "2026-10-23",
    "filings": 4,
    "final_prospectus": "https://www.sec.gov/Archives/edgar/data/1806540/000162828026067048/0001628280-26-067048-index.htm",
    "company_page": "https://equitycapital.markets/company/1806540"
   }
  ],
  "recent_filings": [
   {
    "accession": "0001628280-26-067048",
    "cik": 1806540,
    "company": "Lycia Therapeutics, Inc.",
    "form": "424B4",
    "event": "Final prospectus",
    "filed_date": "2026-10-23",
    "file_number": "333-299300",
    "offering_label": "IPO",
    "offering_status": "Final prospectus",
    "url": "https://www.sec.gov/Archives/edgar/data/1806540/000162828026067048/0001628280-26-067048-index.htm",
    "company_page": "https://equitycapital.markets/company/1806540"
   },
   {
    "accession": "9999999995-26-003321",
    "cik": 1806540,
    "company": "Lycia Therapeutics, Inc.",
    "form": "EFFECT",
    "event": "Declared effective",
    "filed_date": "2026-10-22",
    "file_number": "333-299300",
    "offering_label": "IPO",
    "offering_status": "Final prospectus",
    "url": "https://www.sec.gov/Archives/edgar/data/1806540/999999999526003321/9999999995-26-003321-index.htm",
    "company_page": "https://equitycapital.markets/company/1806540"
   },
   {
    "accession": "0001628280-26-066381",
    "cik": 1806540,
    "company": "Lycia Therapeutics, Inc.",
    "form": "S-1/A",
    "event": "Amendment",
    "filed_date": "2026-10-20",
    "file_number": "333-299300",
    "offering_label": "IPO",
    "offering_status": "Final prospectus",
    "url": "https://www.sec.gov/Archives/edgar/data/1806540/000162828026066381/0001628280-26-066381-index.htm",
    "company_page": "https://equitycapital.markets/company/1806540"
   },
   {
    "accession": "0001628280-26-064973",
    "cik": 1806540,
    "company": "Lycia Therapeutics, Inc.",
    "form": "S-1",
    "event": "Registration filed",
    "filed_date": "2026-10-05",
    "file_number": "333-299300",
    "offering_label": "IPO",
    "offering_status": "Final prospectus",
    "url": "https://www.sec.gov/Archives/edgar/data/1806540/000162828026064973/0001628280-26-064973-index.htm",
    "company_page": "https://equitycapital.markets/company/1806540"
   },
   {
    "accession": "0001628279-26-000815",
    "cik": 1806540,
    "company": "Lycia Therapeutics, Inc.",
    "form": "DRS",
    "event": "Draft made public",
    "filed_date": "2026-07-02",
    "file_number": "377-09537",
    "offering_label": null,
    "offering_status": null,
    "url": "https://www.sec.gov/Archives/edgar/data/1806540/000162827926000815/0001628279-26-000815-index.htm",
    "company_page": "https://equitycapital.markets/company/1806540"
   }
  ]
 }
}